Anti-Melanoma抗体[HMB45 + DT101 + BC199] (ab732)

发表研究结果有使用 ab732?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab732 被引用在 9 文献中.

  • Turajlic S  et al. Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Ann Oncol 25:959-67 (2014). ICC/IF ; Human . PubMed: 24504448
  • Girotti MR  et al. Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma. Cancer Discov 3:158-67 (2013). IHC ; Human . PubMed: 23242808
  • Zirakzadeh AA  et al. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies. J Immunol 190:5847-55 (2013). PubMed: 23630345
  • Lee SJ  et al. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Autophagy 7:829-39 (2011). PubMed: 21685724
  • VanBrocklin MW  et al. Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice. Pigment Cell Melanoma Res 23:531-41 (2010). IHC ; Mouse . PubMed: 20444198
  • Azarova AM  et al. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci U S A 104:11014-9 (2007). IHC ; Mouse . PubMed: 17578914
  • Yamazaki F  et al. Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma. J Invest Dermatol 125:521-5 (2005). PubMed: 16117793
  • Jungbluth AA  et al. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 22:595-602 (1998). PubMed: 9591730
  • Beaty MW  et al. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer 81:57-63 (1997). PubMed: 9100543

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"